Skip to main content
. 2021 Jan 22;105(3-4):181–191. doi: 10.1159/000511245

Table 9.

Follow-up schedule for group 3: patients under active surveillance

Group Histology/stage Therapy Recurrence rate, % Period of time
3Aa Seminoma I None 12–31 Years 1 and 2
3Bb Non-seminomatous GCT (low risk) None 14–22 Years 1 and 2
a

Seminoma stage I.

b

Non-seminomatous GCT stage I without vascular invasion of the primary tumor.